Arbeit Robert D. 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Mar 15, 2012
Insider Transaction Report
Form 4
Arbeit Robert D.
VP Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2012-03-13+9,375→ 84,375 totalExercise: $1.16Exp: 2021-11-28→ Common Stock (9,375 underlying)
Footnotes (1)
- [F1]On December 5, 2011, the reporting person was granted an option to purchase up to an aggregate of 150,000 shares of common stock. Half of the shares subject to such option are subject to satisfaction of performance vesting criteria. On March 13, 2012, certain performance vesting criteria were met with respect to 9,375 of such shares, of which 2,343 shares vested on March 13, 2012 and the remaining 7,032 of which will vest in three equal annual installments beginning on March 13, 2013.